Literature DB >> 12456369

Defined human cellular systems in the study of glioma development.

Russell O Pieper1.   

Abstract

The creation and characterization of permanent cell lines derived from primary human gliomas in the 1960s gave scientists access to unlimited, renewable material in which to study the development of brain tumors. These cells, however, were already tumorigenic and selected for growth in culture, limiting the amount of information that could be gathered about the events that led to the formation of their tumors of origin. In response to these limitations, investigators moved to the study of primary tumors to identify in a correlative fashion the lesions important in tumor formation, and to the use of animal models to gain information about the transformation process. While these approaches have been unarguably successful, they too are limited by their correlative nature (in the case of cytogenetic studies) and their potential lack of direct relevance to human cancer (in the case of mouse models). Recent developments in the isolation and manipulation of human cells have allowed investigators a fresh chance to address questions about brain tumors in a direct fashion. The present review serves as a summary of important recent findings derived from the use of defined human cells in the study of gliomas.

Entities:  

Mesh:

Year:  2003        PMID: 12456369     DOI: 10.2741/983

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  4 in total

Review 1.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

2.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.

Authors:  Sevin Turcan; Daniel Rohle; Anuj Goenka; Logan A Walsh; Fang Fang; Emrullah Yilmaz; Carl Campos; Armida W M Fabius; Chao Lu; Patrick S Ward; Craig B Thompson; Andrew Kaufman; Olga Guryanova; Ross Levine; Adriana Heguy; Agnes Viale; Luc G T Morris; Jason T Huse; Ingo K Mellinghoff; Timothy A Chan
Journal:  Nature       Date:  2012-02-15       Impact factor: 69.504

3.  Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.

Authors:  Adam Ertel; Arun Verghese; Stephen W Byers; Michael Ochs; Aydin Tozeren
Journal:  Mol Cancer       Date:  2006-11-02       Impact factor: 27.401

Review 4.  Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation.

Authors:  Hamid A Bakshi; Hakkim L Faruck; Zeinab Ravesh; Prawej Ansari; J M A Hannan; Rina Hashimoto; Kazuo Takayama; Rabia Farzand; Mohamed M Nasef; Adelaide Mensah; Alaa A A Aljabali; Vijay Mishra; Nitin B Charbe; Rohit Goyal; Poonam Negi; Ángel Serrano-Aroca; Bojlul Bahar; Mohamed El-Tanani; Aaron J Courtenay; Paul McCarron; Iain G Jack; Murtaza M Tambuwala
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.